FX.co ★ Smith+Nephew Announces FDA Clearance For New CATALYSTEM Primary Hip System - Quick Facts

Smith+Nephew (SN.L, SNN) has obtained 510(k) clearance from the FDA for its new CATALYST Primary Hip System. This system aims to meet the evolving needs of primary hip surgeries, particularly with the increasing adoption of anterior approach procedures and the growing significance of Ambulatory Surgery Centers.

The CATALYST Primary Hip System integrates the patent-pending ACCUBROACH Technology. It features a triple-taper stem design that ensures uniform proximal loading. Additionally, the system's reduced distal stem geometry and shorter lengths are optimized for the anterior approach but are versatile enough for all surgical techniques.